COVID-19 Outcomes in CF Patients Similar to General Public, Study Suggests
A 1st: US study finds Gilead drug works against coronavirus
AzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cysti
Case Report Cites IDPN as Nutritional Tool in CF Patients with Kidney Disease
Protein Called TAS2R38 Linked to Respiratory Tract Complications in CF
Staphylococcus Aureus in CF Airways Change With Age, Antibiotic Use, Study Says
Planned CHOICES Trial in Rare CF Mutations Given Regulatory Support
Simulations show how to make gene therapy more effective
McGill spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifen